# Acnb Corp: overview

ACNB · Nasdaq · CIK 715579 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acnb.md) · [Financials](/companies/acnb/financials.md) · [Filings](/companies/acnb/filings.md) · [Insiders](/companies/acnb/insiders.md)

Latest reported revenue: [$52.5m](/filings/0001628280-26-054143.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-054143).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.1](/filings/0001628280-25-050257.md) | [33.2 d](/filings/0001628280-26-017229.md) | [43.5](/filings/0001628280-26-031924.md) | [50.3](/filings/0001628280-26-054143.md) | [50.9](/filings/0001628280-25-050257.md) | [47.2 d](/filings/0001628280-26-017229.md) | [50.5](/filings/0001628280-26-031924.md) | [52.5](/filings/0001628280-26-054143.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [21.1%](/filings/0001628280-25-050257.md) | [19.9% d](/filings/0001628280-26-017229.md) | [(0.6%)](/filings/0001628280-26-054143.md) | [23.2%](/filings/0001628280-26-054143.md) | [29.2%](/filings/0001628280-25-050257.md) | [22.9% d](/filings/0001628280-26-017229.md) | [27.1%](/filings/0001628280-26-054143.md) | [29.0%](/filings/0001628280-26-054143.md) |
| Diluted EPS | $ per share | [0.84](/filings/0001628280-25-050257.md) | not reported | [(0.03)](/filings/0001628280-26-031924.md) | [1.11](/filings/0001628280-26-054143.md) | [1.42](/filings/0001628280-25-050257.md) | not reported | [1.32](/filings/0001628280-26-031924.md) | [1.49](/filings/0001628280-26-054143.md) |
| Free cash flow | $m | [13.3 d](/filings/0001628280-25-050257.md) | [5.3 d](/filings/0001628280-26-017229.md) | [(2.0)](/filings/0001628280-26-031924.md) | [15.4 d](/filings/0001628280-26-054143.md) | [26.2 d](/filings/0001628280-25-050257.md) | [12.6 d](/filings/0001628280-26-017229.md) | [24.0](/filings/0001628280-26-031924.md) | [(4.0) d](/filings/0001628280-26-054143.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [109](/filings/0000715579-25-000030.md) | [115](/filings/0001628280-26-017229.md) | [132](/filings/0001628280-26-017229.md) | [192](/filings/0001628280-26-017229.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [32.8%](/filings/0000715579-25-000030.md) | [27.5%](/filings/0001628280-26-017229.md) | [24.1%](/filings/0001628280-26-017229.md) | [19.3%](/filings/0001628280-26-017229.md) |
| Diluted EPS | $ per share | not reported | [4.15](/filings/0000715579-25-000030.md) | [3.71](/filings/0001628280-26-017229.md) | [3.73](/filings/0001628280-26-017229.md) | [3.60](/filings/0001628280-26-017229.md) |
| Free cash flow | $m | [40.6](/filings/0000715579-23-000015.md) | [37.4](/filings/0000715579-25-000030.md) | [39.4](/filings/0001628280-26-017229.md) | [38.8](/filings/0001628280-26-017229.md) | [52.6](/filings/0001628280-26-017229.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/acnb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $41.9m | 705,130 |  | Added +82,553 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $25.8m | 434,952 |  | Added +7,295 |
| [Private Capital Management, LLC](/funds/1588456.md) | 2026-06-30 | $21.5m | 361,337 |  | Added +1,595 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $21.0m | 353,663 |  | Added +18,819 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $16.1m | 271,775 |  | Added +25,399 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $15.6m | 263,329 |  | Added +79,709 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $13.4m | 225,755 |  | Added +30,177 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $9.6m | 161,818 |  | Reduced −1,160 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $6.3m | 106,511 |  | Added +354 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $5.9m | 98,822 |  | Added +60,228 |

## Recent filings

[All 1,656 filings](/companies/acnb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 08:59 ET | [8-K](/filings/0001628280-26-067750.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-067750 |
| 2026-10-22 | 08:05 ET | [8-K](/filings/0001628280-26-066787.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-066787 |
| 2026-09-25 | 08:02 ET | [8-K](/filings/0001628280-26-063501.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063501 |
| 2026-08-06 | 14:02 ET | [10-Q](/filings/0001628280-26-054143.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054143 |
| 2026-07-29 | 08:35 ET | [8-K](/filings/0001628280-26-050410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-050410 |
| 2026-07-23 | 08:45 ET | [8-K](/filings/0001628280-26-049299.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049299 |
| 2026-05-07 | 13:56 ET | [10-Q](/filings/0001628280-26-031924.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031924 |
| 2026-05-06 | 08:38 ET | [8-K](/filings/0001628280-26-030938.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-030938 |
| 2026-04-29 | 08:46 ET | [8-K](/filings/0001628280-26-028132.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-028132 |
| 2026-04-23 | 09:11 ET | [8-K](/filings/0001628280-26-026708.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-026708 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-017229.md), filed Mar 12, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/4c30ce4f-1583-42d8-b0e0-578edabc288e)

## About the filer

- CIK: 715579
- Tickers: ACNB
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: PA
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 28, 2026, 09:00 ET. No prices; not investment advice.